Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
SOHO 2020
7:38
Immunotherapy for T-cell malignancies
John DiPersio
3:56
Next questions in CAR-based therapies
John DiPersio
3:15
Innovative CAR designs
Renier J. Brentjens
• 10 Sep 2020
4:27
Impact of COVID-19 on CAR T-cell therapies
David L. Porter
• 17 Sep 2020
3:16
Challenges in CAR T-cell therapy
Renier J. Brentjens
• 10 Sep 2020
1:11
Point-of-care CAR T-cells
Marcos de Lima
• 16 Sep 2020
2:42
CAR-T therapy for aggressive B-cell lymphomas
Peter A. Riedell
• 2 Sep 2020
4:51
Anti-CD19 CAR T-cells for adults
David L. Porter
• 9 Sep 2020
2:54
State-of-the-art in CAR-T
Peter A. Riedell
• 10 Sep 2020
5:25
Long-term outcomes of anti-CD19 CAR-T in R/R CLL
David L. Porter
• 16 Sep 2020
3:40
Results of a site-manufactured anti-CD19 CAR-T in nHL
Marcos de Lima
• 24 Aug 2020
5:18
Outlook on the current CAR-T climate
Marcos de Lima
• 24 Aug 2020